Harnessing the power of endogenous protein-metabolite interactions to accelerate drug discovery
By identifying novel regulatory sites on proteins that have the potential to restore function in disease, we aim to reveal targets for novel therapeutics. We are first applying our technology to diseases with unmet medical needs, including inborn errors of metabolism and cancer.
Our cutting-edge AMPS platform allows us to identify binding targets that hold the potential to modify disease processes. This process can be harnessed for a wide range of therapeutic areas.